Expanding Access to State Prescription Drug Monitoring Programs

What it does

The Department of Veterans Affairs (VA) proposes to amend its regulation that governs disclosure of information to and querying of State prescription drug monitoring programs (PDMPs). The rule would clarify certain statutory definitions, including the definition of delegate and licensed health care provider. In doing so, VA would eliminate confusion as to who VA would allow to query the PDMP and would better protect these individuals from any possible adverse action by a State, as long as they are acting within the scope of their VA employment or, if applicable, scope of their contract. The rule would also mandate that VA disclose the specified information to State PDMPs to the extent necessary to prevent misuse and diversion of prescription medicines. This proposed rule would promote safe and effective prescribing of controlled substances to covered individuals and patients who receive VA health care.

The Veterans Affairs Department's summary, as published in the Federal Register.

What it would change

1 part of Title 38 of the Code of Federal Regulations:

38 CFR 1

Before this

No earlier Federal Register document under regulation identifier 2900-AS73 since Jan. 1, 2025.

What happens next and when

Comments must be received on or before July 20, 2026.

The agency's dates, word for word.

Check it yourself

• The document in the Federal Register
• Docket VA-2026-VHA-0166 on Regulations.gov
• Title 38 on eCFR

The record as published

Source: the Federal Register (public domain). The document in the Federal Register